16 October 2020 - Deborah Wilkes
Archived
Johnson & Johnson’s (J&J’s) OTC business reported strong sales growth in the US in the third quarter of 2020 but international sales experienced a significant fall.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.